We participated in the 41st Medicinal Chemistry Symposium at Kyoto TERSA from November 20 to 22.
On November 21, our Representative Director and CEO, Dr. Nakamura, gave an invited lecture, which many participants attended. At the poster discussion session held on the same day, our Principal Investigator, Dr. Otsu, explained our platform technology, focusing on lead compound optimization technology, and many participants attended the session. We also displayed our company booth on November 20 and 21.

We would like to express our sincere gratitude to everyone who attended Dr. Nakamura’s lecture, Dr. Otsu’s poster presentation, and our company booth.